Skip to main content
OpenTrials
Completed

NCT Number: NCT07004426

Symptomatic and Incidental RCC Detection

Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Cell Carcinoma (Kidney Cancer) Adenocarcinoma Benign Renal Neoplasm Carcinoma Carcinoma, Renal Cell Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Renal Carcinoma Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Královské Vinohrady

Prague, 100 34, Czechia

About this study

In the Czech Republic, there is no screening program for renal cell carcinoma. Existing evidence suggests that incidental detection of this cancer tends to occur in its early stages, which are more manageable due to effective treatment options, ultimately reducing renal cancer mortality. This highlights the potential value of evaluating current imaging modalities and determining their role in secondary prevention. This cross-sectional study, based on hospital data, aims to contribute to a better understanding of this issue and to assess the effectiveness of imaging techniques in the early detection of renal cell carcinoma. Furthermore, data analysis may reveal the influence of risk factors on the detection of tumors at various stages.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients over 18 years of age undergoing surgical treatment for renal lesions

Exclusion criteria

  • patients undergoing surgery for non-renal and urotelial carcinoma, including unknown
  • patients with recurrent renal lesions

Treatment and study plan

Surgical treatment of renal lesions

Procedure

Surgical treatment of renal lesions

Primary outcomes

  1. Detection-specific renal cell carcinoma (RCC) proportions

    Time frame: From 2011 to 2020

    Detection-specific renal cell carcinoma (RCC) proportions, defined as the proportion of each detection type relative to all RCC cases. Results will be stratified by stage, histological type, and imaging modality.

Secondary outcomes

  1. Proportion of RCC among neoplastic and non-neoplastic renal lesions

    Time frame: From 2011 to 2020

    Proportion of RCC among neoplastic and non-neoplastic renal lesions, stratified by investigated covariates (e.g., age, sex, smoking status, BMI, or hypertension treatment).

Sponsors and collaborators

Lead sponsor

Charles University, Czech Republic

Other

Collaborators

  • Vascular surgery, University hospital Královské Vinohrady, Prague

Registry information

Official study title

Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities

Acronym: KIDCaD

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 4, 2025
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.